Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development

Mumbai (Maharashtra) [India], May 18: Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), has entered a manufacturing and supply arrangement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited (ABN 70 009 109 755) (ASX:BOT) ('Botanix'), a commercial dermatology company. – Piramal Pharma Solutions…

Key Insights

• This topic is currently trending
• Experts are closely monitoring developments
• It may impact future decisions